Log in to save to my catalogue

Ligand and structure-based Virtual Screening Applied to the SARS-CoV-2 Main Protease: an In Silico R...

Ligand and structure-based Virtual Screening Applied to the SARS-CoV-2 Main Protease: an In Silico R...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7453759

Ligand and structure-based Virtual Screening Applied to the SARS-CoV-2 Main Protease: an In Silico Repurposing Study

About this item

Full title

Ligand and structure-based Virtual Screening Applied to the SARS-CoV-2 Main Protease: an In Silico Repurposing Study

Publisher

England: Newlands Press

Journal title

Future medicinal chemistry, 2020-10, Vol.12 (20), p.1815-1828

Language

English

Formats

Publication information

Publisher

England: Newlands Press

More information

Scope and Contents

Contents

The identification of drugs for the coronavirus disease-19 pandemic remains urgent. In this manner, drug repurposing is a suitable strategy, saving resources and time normally spent during regular drug discovery frameworks. Essential for viral replication, the main protease has been explored as a promising target for the drug discovery process.
...

Alternative Titles

Full title

Ligand and structure-based Virtual Screening Applied to the SARS-CoV-2 Main Protease: an In Silico Repurposing Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7453759

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7453759

Other Identifiers

ISSN

1756-8919

E-ISSN

1756-8927

DOI

10.4155/fmc-2020-0165

How to access this item